Takeda Pharmaceutical Company Limited
Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in Crohn's disease
Last updated:
Abstract:
Provided herein are expanded allogeneic adipose tissue-derived stromal stem cells for use in treating complex perianal fistulas in Crohn's Disease.
Status:
Grant
Type:
Utility
Filling date:
25 Jun 2019
Issue date:
15 Mar 2022